Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Current Progress of Avian Vaccines Against West Nile Virus.

Jiménez de Oya N, Escribano-Romero E, Blázquez AB, Martín-Acebes MA, Saiz JC.

Vaccines (Basel). 2019 Sep 23;7(4). pii: E126. doi: 10.3390/vaccines7040126. Review.

2.

Lipid Metabolism as a Source of Druggable Targets for Antiviral Discovery against Zika and Other Flaviviruses.

Martín-Acebes MA, Jiménez de Oya N, Saiz JC.

Pharmaceuticals (Basel). 2019 Jun 21;12(2). pii: E97. doi: 10.3390/ph12020097. Review.

3.

A Recombinant Subviral Particle-Based Vaccine Protects Magpie (Pica pica) Against West Nile Virus Infection.

Jiménez de Oya N, Escribano-Romero E, Camacho MC, Blazquez AB, Martín-Acebes MA, Höfle U, Saiz JC.

Front Microbiol. 2019 Jun 5;10:1133. doi: 10.3389/fmicb.2019.01133. eCollection 2019.

4.

Targeting host metabolism by inhibition of acetyl-Coenzyme A carboxylase reduces flavivirus infection in mouse models.

Jiménez de Oya N, Esler WP, Huard K, El-Kattan AF, Karamanlidis G, Blázquez AB, Ramos-Ibeas P, Escribano-Romero E, Louloudes-Lázaro A, Casas J, Sobrino F, Hoehn K, James DE, Gutiérrez-Adán A, Saiz JC, Martín-Acebes MA.

Emerg Microbes Infect. 2019;8(1):624-636. doi: 10.1080/22221751.2019.1604084.

5.

A Vaccine Based on a Modified Vaccinia Virus Ankara Vector Expressing Zika Virus Structural Proteins Controls Zika Virus Replication in Mice.

Pérez P, Q Marín M, Lázaro-Frías A, Jiménez de Oya N, Blázquez AB, Escribano-Romero E, S Sorzano CÓ, Ortego J, Saiz JC, Esteban M, Martín-Acebes MA, García-Arriaza J.

Sci Rep. 2018 Nov 26;8(1):17385. doi: 10.1038/s41598-018-35724-6.

6.

Direct Activation of Adenosine Monophosphate-Activated Protein Kinase (AMPK) by PF-06409577 Inhibits Flavivirus Infection through Modification of Host Cell Lipid Metabolism.

Jiménez de Oya N, Blázquez AB, Casas J, Saiz JC, Martín-Acebes MA.

Antimicrob Agents Chemother. 2018 Jun 26;62(7). pii: e00360-18. doi: 10.1128/AAC.00360-18. Print 2018 Jul.

7.

High susceptibility of magpie (Pica pica) to experimental infection with lineage 1 and 2 West Nile virus.

Jiménez de Oya N, Camacho MC, Blázquez AB, Lima-Barbero JF, Saiz JC, Höfle U, Escribano-Romero E.

PLoS Negl Trop Dis. 2018 Apr 10;12(4):e0006394. doi: 10.1371/journal.pntd.0006394. eCollection 2018 Apr.

8.

Antibody-Dependent Enhancement and Zika: Real Threat or Phantom Menace?

Martín-Acebes MA, Saiz JC, Jiménez de Oya N.

Front Cell Infect Microbiol. 2018 Feb 15;8:44. doi: 10.3389/fcimb.2018.00044. eCollection 2018. Review. No abstract available.

9.

Zika virus infection confers protection against West Nile virus challenge in mice.

Vázquez-Calvo Á, Blázquez AB, Escribano-Romero E, Merino-Ramos T, Saiz JC, Martín-Acebes MA, Jiménez de Oya N.

Emerg Microbes Infect. 2017 Sep 20;6(9):e81. doi: 10.1038/emi.2017.68.

10.

Pathogen-specific B-cell receptors drive chronic lymphocytic leukemia by light-chain-dependent cross-reaction with autoantigens.

Jiménez de Oya N, De Giovanni M, Fioravanti J, Übelhart R, Di Lucia P, Fiocchi A, Iacovelli S, Efremov DG, Caligaris-Cappio F, Jumaa H, Ghia P, Guidotti LG, Iannacone M.

EMBO Mol Med. 2017 Nov;9(11):1482-1490. doi: 10.15252/emmm.201707732.

11.

Extinction of West Nile Virus by Favipiravir through Lethal Mutagenesis.

Escribano-Romero E, Jiménez de Oya N, Domingo E, Saiz JC.

Antimicrob Agents Chemother. 2017 Oct 24;61(11). pii: e01400-17. doi: 10.1128/AAC.01400-17. Print 2017 Nov.

12.

Antiviral Properties of the Natural Polyphenols Delphinidin and Epigallocatechin Gallate against the Flaviviruses West Nile Virus, Zika Virus, and Dengue Virus.

Vázquez-Calvo Á, Jiménez de Oya N, Martín-Acebes MA, Garcia-Moruno E, Saiz JC.

Front Microbiol. 2017 Jul 11;8:1314. doi: 10.3389/fmicb.2017.01314. eCollection 2017.

13.

Antiviral Activity of Nordihydroguaiaretic Acid and Its Derivative Tetra-O-Methyl Nordihydroguaiaretic Acid against West Nile Virus and Zika Virus.

Merino-Ramos T, Jiménez de Oya N, Saiz JC, Martín-Acebes MA.

Antimicrob Agents Chemother. 2017 Jul 25;61(8). pii: e00376-17. doi: 10.1128/AAC.00376-17. Print 2017 Aug.

14.

Prevalence of hepatitis E virus (HEV) antibodies in Serbian blood donors.

Petrović T, Lupulović D, Jiménez de Oya N, Vojvodić S, Blázquez AB, Escribano-Romero E, Martín-Acebes MA, Potkonjak A, Milošević V, Lazić S, Saiz JC.

J Infect Dev Ctries. 2014 Oct 15;8(10):1322-7. doi: 10.3855/jidc.4369.

15.

Bisphosphonates target B cells to enhance humoral immune responses.

Tonti E, Jiménez de Oya N, Galliverti G, Moseman EA, Di Lucia P, Amabile A, Sammicheli S, De Giovanni M, Sironi L, Chevrier N, Sitia G, Gennari L, Guidotti LG, von Andrian UH, Iannacone M.

Cell Rep. 2013 Oct 31;5(2):323-30. doi: 10.1016/j.celrep.2013.09.004. Epub 2013 Oct 10.

16.

Characterization of hepatitis E virus recombinant ORF2 proteins expressed by vaccinia viruses.

Jiménez de Oya N, Escribano-Romero E, Blázquez AB, Lorenzo M, Martín-Acebes MA, Blasco R, Saiz JC.

J Virol. 2012 Aug;86(15):7880-6. doi: 10.1128/JVI.00610-12. Epub 2012 May 16.

17.

Widespread distribution of hepatitis E virus in Spanish pig herds.

Jiménez de Oya N, de Blas I, Blázquez AB, Martín-Acebes MA, Halaihel N, Gironés O, Saiz JC, Escribano-Romero E.

BMC Res Notes. 2011 Oct 14;4:412. doi: 10.1186/1756-0500-4-412.

18.

West Nile virus replication requires fatty acid synthesis but is independent on phosphatidylinositol-4-phosphate lipids.

Martín-Acebes MA, Blázquez AB, Jiménez de Oya N, Escribano-Romero E, Saiz JC.

PLoS One. 2011;6(9):e24970. doi: 10.1371/journal.pone.0024970. Epub 2011 Sep 20.

19.

Maternal transfer of antibodies to the offspring after mice immunization with insect larvae-derived recombinant hepatitis E virus ORF-2 proteins.

Jiménez de Oya N, Alonso-Padilla J, Blázquez AB, Escribano-Romero E, Escribano JM, Saiz JC.

Virus Res. 2011 Jun;158(1-2):28-32. doi: 10.1016/j.virusres.2011.02.019. Epub 2011 Mar 2.

PMID:
21376089
20.

Evaluation of an enzyme-linked immunosorbent assay for detection of West Nile virus infection based on a recombinant envelope protein produced in Trichoplusia ni larvae.

Alonso-Padilla J, Jiménez de Oya N, Blázquez AB, Loza-Rubio E, Escribano JM, Saiz JC, Escribano-Romero E.

J Virol Methods. 2010 Jun;166(1-2):37-41. doi: 10.1016/j.jviromet.2010.02.013. Epub 2010 Feb 17.

PMID:
20170681
21.

Serological immunoassay for detection of hepatitis E virus on the basis of genotype 3 open reading frame 2 recombinant proteins produced in Trichoplusia ni larvae.

Jiménez de Oya N, Galindo I, Gironés O, Duizer E, Escribano JM, Saiz JC.

J Clin Microbiol. 2009 Oct;47(10):3276-82. doi: 10.1128/JCM.00750-09. Epub 2009 Aug 5.

22.

[Hepatitis E virus: zoonotic implications].

Jiménez de Oya N, Escribano-Romero E, Blázquez AB, Saiz JC.

Gastroenterol Hepatol. 2007 Aug-Sep;30(7):408-18. Review. Spanish.

PMID:
17692200

Supplemental Content

Loading ...
Support Center